This is a company that I have been following for several years now and the price goes through cycles of growth as they expand overseas with private health care. The current situation as we "come out" of COVID is unclear but I see the potential for an upward cycle as people are able to return to using the medical system again. Will this trend return to previous highs or become a value trap? Only time will tell, but I am happy to take a small position to help follow the company closer.

An investor that I follow, Jun Bei Liu, had RHC as her recommendation focus for 2023 on Livewire, quoted below:

Jun Bei Liu: The best-performing stock for 2023 in my view is going to be Ramsay. We're a big believer in the premium asset that it holds. Its share price is very depressed because of its earnings, which COVID has impacted. It is one of the very few companies that is still yet to recover to pre-COVID levels. We know the waiting list is very long for public hospitals, and that generally translates straight into private hospital volumes. And it is already on the way up. This company will double its earnings and grow phenomenally just recovering from COVID. 

And then on top of that, there's a huge backlog they need to work through, which will take years. The company is trading almost at its asset value. Clearly, the private equity bid stuffed up the valuation somewhat, but now it's back below the pre-private equity bid value. And to me, this is a really good stock to hold, particularly in a slowing economic environment as its earnings are going to grow regardless of the economic outlook.